Construction and characterization of mutants of the TEM-1 β-lactamase containing amino acid substitutions associated with both extended-spectrum resistance and resistance to β-lactamase inhibitors

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 8, 1999, Pages 1881-1887

  Stapleton, Paul D ^a,b   Shannon, Kevin P ^b   French, Gary L ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AZTREONAM; BETA LACTAMASE; BETA LACTAMASE INHIBITOR; CEFALORIDINE; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CHLORAMPHENICOL; CLAVULANIC ACID; NITROCEFIN; PIPERACILLIN; TAZOBACTAM; TEMOCILLIN; TETRACYCLINE; TICARCILLIN;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITOR INTERACTION; ESCHERICHIA COLI; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

EID: 0032816956     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.8.1881     Document Type: Article

References (32)

1. Belaaouaj, A., C. Lapoumeroulie, M. M. Canica, G. Vedel, P. Névot, R. Krishnamoorthy, and G. Paul. 1994. Nucleotide sequences of the genes coding for the TEM-like β-lactamases IRT-1 and IRT-2 (formerly called TRI-1 and TRI-2). FEMS Microbiol. Lett. 120:75-80.
2. Bonomo, R. A., J. R. Knox, S. D. Rudin, and D. M. Shlaes. 1997. Construction and characterization of an OHIO-1 β-lactamase bearing Met69Ile and Gly238Ser mutations. Antimicrob. Agents Chemother. 41:1940-1943.
3. Bret, L., E. B. Chaibi, C. Chanal-Claris, D. Sirot, R. Labia, and J. Sirot. 1997. Inhibitor-resistant TEM (IRT) β-lactamases with different substitutions at position 244. Antimicrob. Agents Chemother. 41:2547-2549.
4. Bret, L., C. Channel, D. Sirot, R. Labia, and J. Sirot. 1996. Characterization of an inhibitor-resistant enzyme IRT-2 derived from TEM-2 β-lactamase produced by Proteus mirabilis strains. J. Antimicrob. Chemother. 38:183-191.
5. Brun, T., J. Péduzzi, M. M. Caniça, G. Paul, P. Névot, M. Barthélémy, and R. Labia. 1994. Characterization and amino acid sequence of IRT-4, a novel TEM-type enzyme with a decreased susceptibility to β-lactamase inhibitors. FEMS Microbiol. Lett. 120:111-118.
6. Bush, K., G. A. Jacoby, and A. A. Medeiros. 1995. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39:1211-1233.
7. 276. Antimicrob. Agents Chemother. 42:1323-1328.
8. Chaibi, E. B., J. Péduzzi, M. Barthélémy, and R. Labia. 1997. Are TEM β-lactamases encoded by pBR322 and Bluescript plasmids enzymatically indistinguishable? J. Antimicrob. Chemother. 39:668-669.
9. Chaibi, E. B., J. Péduzzi, S. Farzaneh, M. Barthélémy, D. Sirot, and R. Labia. 1998. Clinical inhibitor-resistant mutants of the β-lactamase TEM-1 at amino-acid position 69. Kinetic analysis and molecular modelling. Biochim. Biophys. Acta 1382:38-46.
10. Delaire, M., R. Labia, J. P. Samama, and J. M. Masson. 1992. Site-directed mutagenesis at the active site of Escherichia coli TEM-1 β-lactamase. Suicide inhibitor-resistant mutants reveal the role of arginine 244 and methionine 69 in catalysis, J. Biol. Chem. 267:20600-20606.
11. Farzaneh, S., E. B. Chaibi, I. Peduzzi, M. Barthélémy, R. Labia, J. Blazquez, and F. Baquero. 1996. Implication of Ile-69 and Thr-182 residues in kinetic characteristics of IRT-3 (TEM-32) β-lactamase. Antimicrob. Agents Chemother. 40:2434-2436.
12. Giakkoup, P., V. Miriagou, M. Gazouli, E. Tzelepi, N. J. Legakis, and L. S. Tzouvelekis. 1998. Properties of mutant SHV-5 β-lactamases constructed by substitution of isoleucine or valine for methionine at position 69. Antimicrob. Agents Chemother. 42:1281-1283.
13. Henquell, C., C. Chanal, D. Sirot, R. Labia, and J. Sirot. 1995. Molecular characterization of nine different types of mutants among 107 inhibitor-resistant TEM β-lactamases from clinical isolates of Escherichia coli. Antimicrob. Agents Chemother. 39:427-430.
14. Imtiaz, U., E. Billings, J. R. Knox, E. K. Manavathu, S. A. Lerner, and S. Mobashery. 1993. Inactivation of class A β-lactamases by clavulanic acid: the role of arginine-244 in a proposed nonconcerted sequence of events. J. Am. Chem. Soc. 115:4435-4442.
15. Imtiaz, U., E. K. Manavathu, S. Mobashery, and S. A. Lerner. 1994. Reversal of clavulanate resistance conferred by a Ser-244 mutant of TEM-1 β-lactamase as a result of a second mutation (Arg to Ser at position 164) that enhances activity against ceftazidime. Antimicrob. Agents Chemother. 38: 1134-1139.
16. Knox, J. R. 1995. Extended-spectrum and inhibitor-resistant TEM-type β-lactamases: mutations, specificity, and three-dimensional structure. Antimicrob. Agents Chemother. 39:2593-2601.
17. Kunkel, T. A., J. D. Roberts, and R. A. Zkour. 1987. Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol. 154:367-382.
18. Livermore, D. M. 1995. β-Lactamases in laboratory and clinical resistance. Clin. Microbiol. Rev. 8:557-584.
19. Matagne, A., J. Lamotte-Brasseur, and J.-M. Frére. 1998. Catalytic properties of class A β-lactamases: efficiency and diversity. Biochem. J. 330:581-598.
20. Nikaido, H. 1994. Prevention of drug access to bacterial targets: permeability barriers and active efflux. Science 264:382-388.
21. Saves, I., O. Burlet-Schiltz, P. Swarén, F. Lefèvre, J.-M. Masson, J.-C. Promé, and J.-P. Samama. 1995. The asparagine to aspartic acid substitution at position 276 of TEM-35 and TEM-36 is involved in the β-lactamase resistance to clavulanic acid. J. Biol. Chem. 270:18240-18245.
22. Sirot, D., C. Recule, E. B. Cbaibi, L. Bret, J. Croize, C. Chanal-Claris, R. Labia, and J. Sirot. 1997. A complex mutant of TEM-1 β-lactamase with mutations encountered in both IRT-4 and extended-spectrum TEM-15, produced by an Escherichia coli clinical isolate. Antimicrob. Agents Chemother. 41:1322-1325.
23. Sowek, J. A., S. B. Singer, S. Ohringer, M. F. Malley, T. J. Dougherty, J. Z. Gougoutas, and K. Bush. 1991. Substitution of lysine at position 104 or 240 of TEM-1pTZ18R β-lactamase enhances the effect of serine-164 substitution on hydrolysis or affinity for cephalosporins and the monobactam aztreonam. Biochemistry 30:3179-3188.
24. Spratt, B. G. 1994. Resistance to antibiotics mediated by target alterations. Science 265:388-393.
25. Stapleton, P., K. Shannon, and I. Phillips. 1995. The ability of β-lactam antibiotics to select mutants with derepressed β-lactamase synthesis from Citrobacter freundii. J. Antimicrob. Chemother. 36:483-496.
26. Stapleton, P., P.-J. Wu, A. King, K. Shannon, G. French, and I. Phillips. 1995. Incidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Escherichia coli. Antimicrob. Agents Chemother. 39:2479-2483.
27. Strynadka, N. C. J., H. Adachi, S. E. Jensen, K. Johns, A. Sielecki, C. Betzel, K. Sutoh, and M. N. G. James. 1992. Molecular structure of the acyl-enzyme intermediate in β-lactam hydrolysis at 1.7 Å resolution. Nature 359:700-705.
28. Sutcliffe, J. G. 1978. Nucleotide sequence of the ampicillin resistance gene of Escherichia coli plasmid pBR322. Proc. Natl. Acad. Sci. USA 75:3737-3741.
29. Vakulenko, S. B., B. Geryk, L. P. Kotra, S. Mobashery, and S. A. Lerner. 1998. Selection and characterization of β-lactam-β-lactamase inactivator-resistant mutants following PCR mutagenesis of the TEM-1 β-lactamase gene. Antimicrob. Agents Chemother. 42:1542-1548.
30. Vedel, G., A. Belaaouaj, L. Gilly, R. Labia, A. Philippon, P. Névot, and G. Paul. 1992. Clinical isolates of Escherichia coli producing TRI β-lactamases: novel TEM-enzymes conferring resistance to β-lactamase inhibitors. J. Antimicrob. Chemother. 30:449-462.
31. Zafaralla, G., E. K. Manavathu, S. A. Lerner, and S. Mobashery. 1992. Elucidation of the role of arginine-244 in the turnover processes of class A β-lactamases. Biochemistry 31:3847-3852.
32. Zhou, X. Y., F. Bordon, D. Sirot, M.-D. Kitzis, and L. Gutmann. 1994. Emergence of clinical isolates of Escherichia coli producing TEM-1 derivatives or an OXA-1 β-lactamase conferring resistance to β-lactamase inhibitors. Antimicrob. Agents Chemother. 38:1085-1089.